Healthcare Triangle, Inc.

HCTI Healthcare Health Information Services

Healthcare Triangle, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.9 million, up 18.8% from fiscal 2024.

Revenue
+158.4%
EPS
+95.5%
Free cash flow
+67.5%
Total debt
+2,749.9%

Quarter to June 2026, against a year earlier

3.66 0.07 +1.95%
Market cap
$3.2M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
n/a
Altman Z
−3.33
Beneish M
0.56
Dividend safety
n/a

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 14.47%

Capital & Financial Ratios $m

Size
Market Cap 3.19
Revenue ttm 25.68
Net income ttm (17.02)
Free cash flow ttm (17.58)
Net debt Q 9.92
Valuation
P/E 0.00
Forward P/E (0.03) (negative: loss-making)
Price / sales 0.02
Forward P/S Powerpack
Price / FCF 0.00
Price / book 0.02
Financial health
Current ratio Q 0.60 (below 1: weak)
Debt / equity Q 0.24 (at or below 0.5: strong)
Interest coverage Q (45.74)
Growth
Revenue growth Q +158.38% (above 0%: growing)
Operating income growth Q −199.56% (below 0%: shrinking)
EPS, this year +77.05% (at or above 15%: strong)
EPS, next year A +68.91% (at or above 15%: strong)
Revenue, next year A +179.61% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 2.34%
10-year low 10-year high
P/B against its own 10 years 0.22%
10-year low 10-year high
EV/Sales against its own 10 years 27.09%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 1 0 8 2
Receivables 4 1 2 6
Inventory — — — —
Other 1 0 3 2
6 1 13 10
2023 2024 2025 Q'26
Payables 2 3 1 1
ST’ Debt 4 3 11 9
Other 2 2 1 5
8 7 13 16

Compound Annual Growth %

10y 5y 3y
Sales — (15.02%) (32.85%)
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 18.10% (7.06%)

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 (133.15) (31.47) — — —
’25 (2.58k) (700.00) (513.64) 49.74k (3.06k)
’24 (0.42) (4.24k) (3.29k) (3.44k) (16.92k)
’23 (0.79) (0.42) (0.45) (0.42) (2.08)
’22 (0.06) (0.11) (0.65) (19.46k) (2.63)
’21 (0.03) 0.01 (0.07) (0.12) (0.20)
’20 — 0.00 0.01 — 0.08
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 10 9 — — —
’25 4 4 3 3 14
’24 4 3 2 2 12
’23 10 9 8 7 33
’22 11 12 12 11 46
’21 8 10 8 9 35
’20 — 8 7 — 31
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (7) (1) — — —
’25 (6) (3) (1) (7) (17)
’24 0 (1) 1 (1) (1)
’23 (2) (1) 0 1 (2)
’22 0 0 (1) (2) (3)
’21 (2) (1) 0 (3) (7)
’20 — — (2) 1 (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (7) (1) — — —
’25 (6) (3) (3) (7) (18)
’24 0 (1) 1 (1) (1)
’23 (2) (1) 0 1 (2)
’22 0 (2) (2) (2) (6)
’21 (2) (1) 0 (6) (10)
’20 — — (2) 1 (1)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — 29 31 35 46 33 12 14 26 (11.4%) 39 41 35 +36.3%
Gross margin, % — — — 20.35 27.40 29.83 24.62 20.41 24.71 13.61 21.53 (6.7) pt
EBT — — — 2 3 (6) (10) (9) (6) (9) (17) n/m
EBT margin, % — — — 5.63 8.33 (16.80) (20.81) (26.05) (50.93) (68.22) (66.20) (73.9) pt
Net income — 0 — 1 2 (6) (14) (9) (6) (9) (17) n/m
Per share, $
Per share, $ Revenue — — — 8.17 1.12 1.20 12.54 7.95 0.00 4,480.97 183.02 +186.1%
Earnings — — — 0.33 0.08 (0.20) (2.63) (2.08) (16,916.17) (3,063.05) 49,065.66 n/m
Cash flow — — — 1.13 (0.03) (0.24) (0.71) (0.51) 0.00 (5,330.00) (114.24) n/m
Capex — — — (1.04) (0.02) (0.11) (0.91) 0.00 0.00 (485.16) (11.03) +178.6%
Free cash flow — — — 0.09 (0.04) (0.35) (1.62) (0.52) 0.00 (5,815.16) (125.27) n/m
Book value — — — 0.56 0.16 0.55 3.39 (0.33) 0.00 3,207.74 349.96 +322.8%
Shares, m — — — 4 28 29 4 4 0 0 0 (69.0%)
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.0
P/S — — — 9,239,979.33 9,239,979.33 225,357.60 2,245.39 5,362.16 0.00 0.17 0.02 2,673,274.9
P/B — — — 114,114,666.05 114,114,666.05 492,616.20 8,317.09 0.00 0.00 0.94 0.02 32,675,752.3
EV/Sales — — — 9,239,979.35 9,239,979.35 225,357.61 2,245.42 5,362.24 0.30 0.46 0.41 2,673,275.0
EV/FCF — — — (116,117,279.90) (116,117,279.90) (1,102,469.33) (11,487.70) (32,716.34) (1.48) (0.35) (0.59) (33,340,176.4)
Cash, $m
Cash, $m Operating cash flow — — — 4 (1) (7) (3) (2) (1) (17) (16) n/m
Capex — — — (4) 0 (3) (3) 0 — (2) (2) (13.7%)
Free cash flow — — — 0 (1) (10) (6) (2) (1) (18) (18) n/m
Balance, $m
Balance, $m Working capital — — — (1) 1 6 2 (2) (6) 0 (6) n/m
Net debt — — — (1) (1) 0 1 3 3 3 10 n/m
Shareholders’ equity — — — 2 4 16 12 (1) (5) 10 49 +30.9%
Returns, %
Returns, % ROA — — — 28.41 24.31 (33.31) (63.28) (62.89) (135.37) (76.74) (38.60) (105.1) pt
ROIC — — — 104.31 19.98 (20.20) (48.37) (381.70) 0.00 (46.86) (15.59) (151.2) pt
ROE — — — 37.19 74.67 (58.14) (100.68) (157.97) 85.64 188.76 (128.77) +151.6 pt
People
People Employees — — — — 69 77 51 33 36 84 — +4.0%
Revenue/emp, $m — — — 0.00 0.45 0.46 0.90 1.01 0.32 0.17 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 2 Nov 2026

Healthcare Triangle, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
BFRG Bullfrog AI Holdings Inc. $9.1M — (loss-making) — (loss-making) +2,054.00% (above 0%: growing) n/m −5.67% (below 0%: shrinking) 49.63% (658.82%) Compare
HLTHQ Cue Health Inc. $6.9M — (loss-making) — (loss-making) −87.19% (below 0%: shrinking) n/m +50.55% (above 0%: growing) (90.14%) (792.13%) Compare
ACON Aclarion, Inc. $4.5M — (loss-making) — (loss-making) +78.48% (above 0%: growing) n/m −74.22% (below 0%: shrinking) 43.86% (8,164.70%) Compare
MGRX Mangoceuticals, Inc. $4.3M — (loss-making) — −59.07% (below 0%: shrinking) n/m +79.27% (above 0%: growing) 64.24% (1,501.45%) Compare
ZCMD Zhongchao Inc. $4.3M — (loss-making) — +20.44% (above 0%: growing) −550.00% (below 0%: shrinking) +191.85% (above 0%: growing) 41.67% 0.00% Compare
HCTI Healthcare Triangle, Inc. $3.2M 0.0× — (loss-making) +158.38% (above 0%: growing) n/m +67.48% (above 0%: growing) 22.48% (44.28%)
VSEE VSee Health, Inc. $2.8M — (loss-making) — (loss-making) −53.93% (below 0%: shrinking) n/m −257.62% (below 0%: shrinking) 13.20% (172.69%) Compare
WORX SCWorx Corp. $2.0M — (loss-making) — (loss-making) +3.43% (above 0%: growing) n/m +87.99% (above 0%: growing) 46.80% (17.14%) Compare
MSPR MSP Recovery, Inc. $1.5M — (loss-making) — −94.60% (below 0%: shrinking) n/m +60.88% (above 0%: growing) (26.77%) (62,501.52%) Compare
Median of peers $4.3M — — −25.25% — +55.72% 42.77% (725.47%)

All 44 Health Information Services stocks →

Healthcare Triangle, Inc. (HCTI) Latest News

10 Sep

14 Aug

Impact 3 ·

14 May

stockrow.com/HCTI · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com